Lung and Heart/Lung Transplant Program, Temple University School of Medicine, Philadelphia, PA 19140, USA.
Med Clin North Am. 2012 Jul;96(4):827-47. doi: 10.1016/j.mcna.2012.05.006.
Over the last decade, advances in bronchoscopic and surgical techniques have expanded our treatment armamentarium for patients with severe emphysema who previously would have received a pessimistic outlook from their physician. Advances in our understanding of the different COPD phenotypes and its natural history has refined our selection process as to which group of emphysema patients will derive maximum benefit from LVR, bullectomy, or lung transplantation. Because emphysema is a progressive disease, initial treatment with bronchoscopic or surgical LVR or bullectomy does not preclude lung transplantation in the future.
在过去的十年中,支气管镜和外科技术的进步扩大了我们对严重肺气肿患者的治疗手段,这些患者以前从医生那里得到的是悲观的预后。我们对不同 COPD 表型及其自然史的理解的进步,使我们能够更精确地选择哪些肺气肿患者群体将从 LVR、肺大疱切除术或肺移植中获益最大。由于肺气肿是一种进行性疾病,初始的支气管镜或外科 LVR 或肺大疱切除术治疗并不能排除将来进行肺移植。